🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🎯 Potential targets for the treatment of autoimmune hepatitis.

Introducing the 2024 Emerging Liver Advanced Practice Providers! 🤩 Huge congrats to Jillian Hubert, PA-C, Kristy Kiermaier DNP, FNP-BC, and Kristen Knoph, PharmD. Learn more about AASLD Foundation's 2024 awardees at aasldfoundation.org/2024-emerging-…

Sheila Eswaran, MD, MS, Rush University Medical Center, will be moderating Ask the Experts: Living with Liver Cancer on October 10. Register for free here: alf.social/ATELC24

ACG has a growing collection of clinical education modules for the #GIAPP community, perfect for deepening knowledge of the GI care team 🎯NEW! Advanced #IBD 🎯NEW! Advanced #Hepatology FREE login on ACG Education Universe ➡️education.gi.org #GItwitter #Gastroenterology

🍷 Findings from a study at Mass Gen indicate that significant disease burden of ALD in the United States is expected to rise due to increased alcohol consumption during the pandemic👇🏼 mgriblog.org/2022/02/15/spi… #livertwitter #MedTwitter

Virginia Portal 360 Meeting Nancy Reau Andres Duarte-Rojo, MD, MS, PhD Great fun 😁

On September 13, an FDA Gastrointestinal Drug Advisory Committee voted that the benefits of obeticholic acid on clinical outcomes in patients with PBC could not be verified with available data. Learn about the potential implications: shorturl.at/a51c8 #livertwitter

The health of the liver is the topic of Dr. Mark B. Pochapin, MD’s next segment of Chief’s Rounds via SiriusXM live from #ACG2024 with ✅Dr. Nancy Reau ✅Dr. Jasmohan Bajaj ✅Dr. @AtoosaRabiee ✅Dr. #PaulMartin

🪩some glimpses of #ACG2024 Day 2️⃣ ACG Evidence-Based GI: An ACG Publication (EBGI)

Thank you to everyone who attended #ACG2024! 📽️Enjoy "An #ACGfamily Home Movie: #ACG2024 Highlights" youtu.be/WTIn3bxyQtA?si… via YouTube

Immediately after seeing this poster at #TLM23, I asked renumathyd if she would review benign liver lesions for Hepatology Communications She did. And the review is fantastic journals.lww.com/hepcomm/fullte… Authoritative, from a Master of all lesions in the liver

#aasld come cheer for team rush!

#TLM2024 come cheer for team Rush!!

So proud of our 3rd year fellow Zoë Post, MD, MSc and transplant hepatology fellow Aryanna Sousa, MD, MPH on their excellent presentations/arguments for the academic debate at The Liver Meeting! Great job! 👏🏻🤩 #TLM24 AASLD AASLD Foundation

🎇 Happy New Year! In 2024, I had many important conversations on personalized treatment strategies, monitoring, and new therapies for primary biliary cholangitis (PBC). Listen below! ⬇️ hcplive.com/authors/nancy-… #livertwitter #MedTwitter RUSH Internal Medicine HCPLive

GLP-1s not only help with weight loss and blood sugar control but also seem to improve liver health. Data for GLP-1 receptor agonists in improving MASH pathology is encouraging. #livertwitter #MedTwitter RUSH Internal Medicine Medscape medscape.com/viewarticle/wh…

If you're looking for better sleep, a happy gut, and glowing skin, #DryJanuary might be for you. Additional side effects include a healthier heart, liver, and reduced cancer risk ;) Well+Good wellandgood.com/dry-january-he… #livertwitter #MedTwitter #DryJanuaryChallenge

MetALD = The dangerous overlap of metabolic dysfunction + moderate alcohol use. Together, they speed up liver damage, inflammation, & cancer risk. A rising issue as metabolic disorders grow 🍷⚠️ nature.com/articles/s4435… #LiverTwitter #MetALD RUSH Internal Medicine

Insights into immune cells, checkpoint inhibitors, and personalized therapies (using RNA & microbiome analysis) are paving the way for better treatments for autoimmune liver diseases. 🚀 #LiverTwitter #Immunotherapy #PrecisionMedicine Journal of Hepatology clinicalkey.com/#!/content/pla…